Windtree Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Net Income	-20.29	-39.21	-67.64	-32.57	-27.48	-34.76	-24.82	-39.49	-55.17	-44.06	Upgrade
Depreciation & Amortization	0.49	1.06	0.87	0.64	1.11	0.16	0.19	0.26	0.71	0.82	Upgrade
Share-Based Compensation	1.28	3.09	7.24	5.68	6.72	0.96	1.66	1.69	2.24	3.92	Upgrade
Other Operating Activities	5.09	15.61	35.87	0.93	-5.02	3.64	-4.45	3.96	18.72	-1.85	Upgrade
Operating Cash Flow	-13.44	-19.45	-23.66	-25.32	-24.66	-15.78	-21.05	-33.59	-33.5	-41.17	Upgrade
Capital Expenditures	-0.02	0.2	-0.28	-0.29	-0.19	0.01	-0.02	-0.25	-0.19	-0.78	Upgrade
Acquisitions	0	0	0	0	0	0.22	0	0	0	0	Upgrade
Change in Investments	0	0	0	0	13.99	-13.96	0	0	0	0	Upgrade
Investing Cash Flow	-0.02	0.2	-0.28	-0.29	13.8	-13.73	-0.02	-0.25	-0.19	-0.78	Upgrade
Share Issuance / Repurchase	12.39	4.25	32.23	20.39	22.98	32.89	15.9	0.71	32.77	0.46	Upgrade
Debt Issued / Paid	-0.8	-1.17	-3.87	-3.23	-1.06	6	1.4	0	-5.06	-0.08	Upgrade
Other Financing Activities	-	-	1	2.8	-0.15	-0.16	-	-	-	-	Upgrade
Financing Cash Flow	11.6	3.08	29.36	19.96	21.77	38.74	17.3	0.71	27.7	0.38	Upgrade
Exchange Rate Effect	0	0	0	0	0.47	0.09	0	0	0	0	Upgrade
Net Cash Flow	-1.86	-16.18	5.42	-5.65	11.37	9.32	-3.77	-33.13	-5.99	-41.57	Upgrade
Free Cash Flow	-13.45	-19.26	-23.94	-25.61	-24.85	-15.77	-21.07	-33.84	-33.69	-41.95	Upgrade
Free Cash Flow Margin	-	-	-	-	-12552.53%	-882.10%	-1418.79%	-1657.35%	-3413.58%	-1479.68%	Upgrade
Free Cash Flow Per Share	-62.47	-550.14	-870.65	-1472.20	-2046.94	-9478.36	-55299.21	-219759.74	-261178.30	-371230.09	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).